Further deregulation of NHEJ in BCR-ABL1-associated CML patients may arise from decreased expression levels of LIG4 and Artemis (Figure 2A, green arrows), without changes in DNA-PKcs [78]. Here, PRKDC is linked to chronic myelogenous leukemia, BCR-ABL1 positive.